ClinicalTrials.Veeva

Menu

Brain Blood Flow Responses During Exercise

University of Wisconsin (UW) logo

University of Wisconsin (UW)

Status

Active, not recruiting

Conditions

Cerebrovascular Circulation
Magnetic Resonance Imaging

Treatments

Device: MRI

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05864950
Protocol Version 3/22/2023 (Other Identifier)
1RF1NS117746-01 (U.S. NIH Grant/Contract)
A176000 (Other Identifier)
UWF
2022-0512

Details and patient eligibility

About

Brain blood flow will be measured during exercise using magnetic resonance imaging.

Full description

Over 6 million Americans are living with Alzheimer's disease and related dementias and this number is expected to reach over 13 million by 2060. Thus, there is an urgent need for interventions to prevent the development and progression of Alzheimer's disease and related dementias. Regular exercise is currently the most promising strategy as it is repeatedly shown to have neuroprotective benefits. Evidence suggests that the neuroprotective effects of exercise is the result of improved health of blood vessels. Despite the vast amount of evidence on the benefit of exercise on the peripheral vasculature, there is little information regarding brain vascular responses during exercise. This study will investigate the impact of exercise at varying intensities on brain blood flow during exercise, and will also examine the influence of age and sex.

Enrollment

80 estimated patients

Sex

All

Ages

55 to 69 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy men or women between the ages of 55-69 years
  • Demonstrate an exercise history of engaging in aerobic physical activity at least 3 times per week for a minimum of 30 continuous minutes
  • Have experience using cardiovascular exercise equipment (e.g., treadmill, elliptical, upright or recumbent bicycle, stair-stepper)

Exclusion criteria

  • Outside of specified age range
  • Do not have experience using cardiovascular exercise equipment
  • Do not meet the physical activity criteria
  • Present with a history or evidence of hepatic, renal, hematological disease, cardiovascular disease including uncontrolled hypertension, peripheral vascular disease, stroke/neurovascular disease, and diabetes
  • have a body mass index ≥35 kg/m2
  • are ≥ 71 inches (180 cm) in height
  • have any contraindications to MRI
  • currently use or have a history of use of tobacco or illegal substances
  • have current and/or a history of depression or other mood related disorders (those with mild depression and/or anxiety that is controlled with medication and/or therapy will not be excluded)
  • vulnerable populations (e.g., pregnant women, prisoners, individuals lacking capacity to consent)
  • if the desired moderate/vigorous exercise intensity corresponds to > 350 watts on the stepper device

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

80 participants in 1 patient group

Middle-Aged Adults
Experimental group
Description:
Middle-Aged Adults between 55-69 years of age.
Treatment:
Device: MRI

Trial contacts and locations

1

Loading...

Central trial contact

Jill N Barnes, PhD; Anna J Howery, MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems